Close

Medicines Co. (MDCO) Misses Q2 EPS by 23c

July 29, 2015 7:27 AM EDT

Medicines Co. (NASDAQ: MDCO) reported Q2 EPS of ($0.71), $0.23 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $90.5 million versus the consensus estimate of $122.58 million.

For earnings history and earnings-related data on Medicines Co. (MDCO) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings